Malignant neoplasm of bronchus and lung, unspecified. Short description: Mal neo bronch/lung NOS. ICD-9-CM 162.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 162.9 should only be used for claims with a date of service on or before September 30, 2015.
Billable Medical Code for Malignant Neoplasm of Bronchus and Lung, Unspecified Diagnosis Code for Reimbursement Claim: ICD-9-CM 162.9. Code will be replaced by October 2015 and relabeled as ICD-10-CM 162.9. The Short Description Is: Mal neo bronch/lung NOS. Known As
ICD-9 Code 162.9 Malignant neoplasm of bronchus and lung, unspecified. ICD-9 Index; Chapter: 140–239; Section: 160-165; Block: 162 Malignant neoplasm of trachea, bronchus, and lung; 162.9 - Mal neo bronch/lung NOS
Objective: To determine the validity of using ICD-9-CM codes indicating metastases as a proxy to classify lung cancer patients by stage of disease. Research design: This retrospective database analysis used diagnosis codes to classify subjects to either localized or advanced-stage disease and then compared this classification to the tumor registry staging, which was considered as …
ICD-9-CM Code | Description |
---|---|
492.8 | Other emphysema |
493.22 | Chronic obstructive asthma with acute exacerbation |
496 | Chronic airway obstruction, not elsewhere classified |
518.81 | Acute respiratory failure |
ICD-9-CM | ICD-10-CM |
---|---|
13,000 codes | 68,000 codes |
17 chapters | 21 chapters (order of chapters different than ICD-9-CM) |
Separate V and E codes. (Supplemental Classification for Health Encounters and Injuries/Poisonings) | Supplemental Classification incorporated into main classification |
162.9 is a legacy non-billable code used to specify a medical diagnosis of malignant neoplasm of bronchus and lung, unspecified. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.
It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer. High levels of pollution, radiation and asbestos exposure may also increase risk.
An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
Lung cancer is one of the most common cancers in the world. It is a leading cause of cancer death in men and women in the United States. Cigarette smoking causes most lung cancers. The more cigarettes you smoke per day and the earlier you started smoking, the greater your risk of lung cancer .
Vol. 23 No. 7 P. 27. Lung cancer is any type of malignant growth in the lungs that occurs when cells in the lung start to grow rapidly and uncontrollably. Smoking puts people at the highest risk of developing lung cancer, though exposure to secondhand smoke is also a major cause.
There are two major types of lung cancer, which is determined by the appearance of the cancerous cells under a microscope: • Small-cell lung cancer: Also called oat cell cancer, it is the more aggressive type and frequently metastasizes to other sites such as the liver, bone, and brain.
Lung cancer is any type of malignant growth in the lungs that occurs when cells in the lung start to grow rapidly and uncontrollably. Smoking puts people at the highest risk of developing lung cancer, though exposure to secondhand smoke is also a major cause.
Smoking puts people at the highest risk of developing lung cancer, though exposure to secondhand smoke is also a major cause. Lung cancer is the leading cause of cancer death among both men and women. Lung cancer does not typically produce symptoms in the disease’s early stages.
There are two major types of lung cancer, which is determined by the appearance of the cancerous cells under a microscope: • Small-cell lung cancer: Also called oat cell cancer, it is the more aggressive type and frequently metastasizes to other sites such as the liver, bone, and brain.
Advanced lung cancer eventually metastasizes to nearby lymph nodes or other tissues in the chest, including the other lung. In many cases, lung cancer spreads to other organs in the body such as the bone (198.5), brain (198.3), liver (197.7), and adrenal glands (198.7). Diagnosis.
When symptoms do appear in the more advanced stages, they may include the following: • coughing (a new cough or a change in a chronic cough); • hemoptysis; • chest pain; • shortness of breath; • wheezing; • hoarseness; • weight loss; • bone pain; and/or.
ICD-9-CM 199.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 199.1 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Malignant tumor involving an organ by direct extension from uterine cervix. Malignant tumor involving an organ by direct extension from uterus. Malignant tumor involving an organ by direct extension from vagina. Malignant tumor involving an organ by separate metastasis from bladder.
Malignant neoplasm. Malignant neoplasm associated with AIDS. Malignant neoplastic disease. Malignant neoplastic disease in pregnancy. Malignant neoplastic disease postpartum. Malignant tumor involving an organ by direct extension from bladder. Malignant tumor involving an organ by direct extension from endometrium.